Download video

Closing the Healthcare Gaps in the Management of Moderate-to-Severe Atopic Dermatitis with Biologics

35 views

FC TV

1 year ago

Closing the Healthcare Gaps in the Management of Moderate-to-Severe Atopic Dermatitis with Biologics

Closing the Healthcare Gaps in the Management of Moderate-to-Severe Atopic Dermatitis with Biologics

Closing the Healthcare Gaps in the Management of Moderate-to-Severe Atopic Dermatitis with Biologics
0:39
Closing the Healthcare Gaps in the Management of Moderate-to-Severe Atopic Dermatitis with Biologics
by FC TV
Using Biologics to Manage Moderate to Severe Atopic Dermatitis
57:06
Using Biologics to Manage Moderate to Severe Atopic Dermatitis
by PeerView CME
Reframing the Management Approach for Moderate to Severe Atopic Dermatitis
30:27
Reframing the Management Approach for Moderate to Severe Atopic Dermatitis
by Medscape
Clinical SnapShots of Moderate-to-Severe Atopic Dermatitis
4:28
Clinical SnapShots of Moderate-to-Severe Atopic Dermatitis
by ExchangeCME
Treatment of Moderate-Severe Atopic Dermatitis: Line 7 Stop 3 Clinical Efficacy
3:43
Treatment of Moderate-Severe Atopic Dermatitis: Line 7 Stop 3 Clinical Efficacy
by Annenberg Center for Health Sciences
Kim Kjøller, MD: Tralokinumab for Atopic Dermatitis
2:28
Kim Kjøller, MD: Tralokinumab for Atopic Dermatitis
by HCPLive
Emerging Therapies - Shifting Paradigms, Emerging Treatments in Moderate to Severe Atopic Dermatitis
12:05
Emerging Therapies - Shifting Paradigms, Emerging Treatments in Moderate to Severe Atopic Dermatitis
by Annenberg Center for Health Sciences
Overcoming Challenges in the Management of Moderate to Severe AD
30:10
Overcoming Challenges in the Management of Moderate to Severe AD
by PeerView CME
Economic Burden of Atopic Dermatitis Treatment
5:15
Economic Burden of Atopic Dermatitis Treatment
by AJMCtv
Webinar: Accessing Care and Setting and Maintaining Atopic Dermatitis Goals
12:14
Webinar: Accessing Care and Setting and Maintaining Atopic Dermatitis Goals
by AAFA National
Tralokinumab + TCS in AD: phase III results, J.I. Silverberg et al
5:56
Tralokinumab + TCS in AD: phase III results, J.I. Silverberg et al
by British Journal of Dermatology
Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies
6:52
Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies
by Specialty Pharmacy Times
Managing Atopic Dermatitis with Dupilumab: What You Need to Know
3:28
Managing Atopic Dermatitis with Dupilumab: What You Need to Know
by Angeline Yong Dermatology